Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 1 Odds ratios (OR) with 95% confidence interval (CI) for glioma and acoustic neuroma in case-control studies in the highest category for cumulative mobile phone use in hoursa

From: Scientific evidence invalidates health assumptions underlying the FCC and ICNIRP exposure limit determinations for radiofrequency radiation: implications for 5G

 

Glioma

Acoustic neuroma

All

Ipsilateral

All

Ipsilateral

OR

95% CI

OR

95% CI

OR

95% CI

OR

95% CI

Interphone [117, 119]

Cumulative use ≥1640 hr

1.40

1.03–1.89

1.96

1.22–3.16

1.32

0.88–1.97

2.33

1.23–4.40

Coureau et al. [118] Cum use ≥896 hr

2.89

1.41–5.93

2.11

0.73–6.08

    

Hardell et al. [115, 116]

Cumulative use ≥1640 hr

2.13

1.61–2.82

3.11

2.18–4.44

2.40

1.39–4.16

3.18

1.65–6.12

Meta-analysis

longest cumulative use

1.90

1.31–2.76

2.54

1.83–3.52

1.73

0.96–3.09

2.71

1.72–4.28

  1. a Note Hardell et al. [115, 116] also assessed use of cordless phones